John C. Byrd

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Karl W. Kroll, C. Bloomfield, J. Byrd, 2017, Leukemia.

Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

Karl W. Kroll, C. Bloomfield, J. Byrd, 2016, Leukemia.

CD19 CAR-T cells combined with ibrutinib to induce complete remission in CLL.

J. Byrd, D. Porter, C. June, 2017 .

Analysis of the Effects of the Bruton’s tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fc (cid:2) Receptor (Fc (cid:2) R) Function

Amanda R. Campbell, Jonathan P Butchar, S. Tridandapani, 2020 .

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells

Jeffrey A Jones, K. Williams, L. Andritsos, 2014, Leukemia.

BAFF and related proteins: a new therapeutic target for B-cell malignancies

John C. Byrd, 2004 .

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)

C. Bloomfield, J. Byrd, S. Volinia, 2016, Leukemia.